PD
CGON icon

Point72 (DIFC)’s CG Oncology CGON Stock Holding History

Point72 (DIFC)’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$442K Buy
10,972
+1,733
+19% +$50.4K 0.03% 299
2025
Q2 		$240K Buy
+9,239
New +$223K 0.01% 742
2024
Q2 		– Sell
-24,807
Closed -$1.09M – 1509
2024
Q1 		$1.09M Buy
+24,807
New +$1.01M 0.03% 553

Other funds holding CGON

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Point72 (DIFC)'s CGON Position: Q3 2025 in Review

Point72 (DIFC) increased its CG Oncology (CGON) stake by 19% in Q3 2025, buying an estimated $50.4K and bringing the position to 10,972 shares worth $442K. The position accounts for 0.03% of the portfolio, ranked #299.

Point72 (DIFC) first reported a position in CGON in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.09M in Q1 2024. 176 funds tracked by Wall St. Rank hold CGON as of Q3 2025.

  • Point72 (DIFC) held 10,972 shares of CG Oncology worth $442K as of Q3 2025.
  • Point72 (DIFC) bought 1,733 CG Oncology shares in Q3 2025, an estimated $50.4K.
  • CG Oncology made up 0.03% of Point72 (DIFC)'s portfolio in Q3 2025, its #299 holding.
  • Point72 (DIFC) first reported a position in CG Oncology in Q1 2024 and has held it in 3 quarters since.
  • Point72 (DIFC)'s CG Oncology position peaked at $1.09M in Q1 2024.
  • 176 funds tracked by Wall St. Rank held CG Oncology as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.